What's Going On With Priveterra, AEON Biopharma Shares Today?
Portfolio Pulse from Adam Eckert
Priveterra Acquisition Corp (PMGM) has completed its business combination with AEON Biopharma, changing its name to AEON Biopharma and commencing trading on the NYSE under the ticker 'AEON'. AEON also announced the closing of funding arrangements of up to $125 million, which will help fund its clinical development of ABP-450 to treat various medical conditions.
July 24, 2023 | 2:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AEON Biopharma has commenced trading on the NYSE under the ticker 'AEON' following its merger with Priveterra. The company has also secured up to $125 million in funding for its clinical development.
The merger with Priveterra and the commencement of trading on the NYSE under the ticker 'AEON' are significant events for AEON Biopharma. The additional funding of up to $125 million will support the company's clinical development, which could potentially lead to positive outcomes and drive the stock price up in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEUTRAL IMPACT
Priveterra has completed its merger with AEON Biopharma and has ceased trading under the ticker 'PMGM'.
As Priveterra has merged with AEON Biopharma and changed its name, it will no longer be trading under the ticker 'PMGM'. This is a significant event for the company, but it does not necessarily indicate a positive or negative impact on the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100